276 related articles for article (PubMed ID: 1978640)
1. Surgical management of pheochromocytoma with the use of metyrosine.
Perry RR; Keiser HR; Norton JA; Wall RT; Robertson CN; Travis W; Pass HI; Walther MM; Linehan WM
Ann Surg; 1990 Nov; 212(5):621-8. PubMed ID: 1978640
[TBL] [Abstract][Full Text] [Related]
2. Metyrosine and pheochromocytoma.
Steinsapir J; Carr AA; Prisant LM; Bransome ED
Arch Intern Med; 1997 Apr; 157(8):901-6. PubMed ID: 9129550
[TBL] [Abstract][Full Text] [Related]
3. Pheochromocytoma resistant to alpha-adrenergic blockade.
Hauptman JB; Modlinger RS; Ertel NH
Arch Intern Med; 1983 Dec; 143(12):2321-3. PubMed ID: 6139989
[TBL] [Abstract][Full Text] [Related]
4. The combination of doxazosin and metyrosine as a preoperative treatment for pheochromocytomas and paragangliomas.
Ohmachi Y; Yamamoto M; Inaba Y; Makino S; Urai S; Matsumoto R; Bando H; Kanie K; Tsujimoto Y; Motomura Y; Sasaki Y; Oi-Yo Y; Yamamoto N; Suzuki M; Takahashi M; Iguchi G; Kanzawa M; Furukawa J; Shigemura K; Mizobuchi S; Ogawa W; Fukuoka H
Endocrine; 2024 May; 84(2):694-703. PubMed ID: 38206436
[TBL] [Abstract][Full Text] [Related]
5. Failure of metyrosine therapy for preoperative management of pheochromocytoma: a case report.
Thanapaalasingham K; Pollmann AS; Schelew B
Can J Anaesth; 2015 Dec; 62(12):1303-7. PubMed ID: 26362800
[TBL] [Abstract][Full Text] [Related]
6. Perioperative hemodynamics and outcomes of patients on metyrosine undergoing resection of pheochromocytoma or paraganglioma.
Butz JJ; Weingarten TN; Cavalcante AN; Bancos I; Young WF; McKenzie TJ; Schroeder DR; Martin DP; Sprung J
Int J Surg; 2017 Oct; 46():1-6. PubMed ID: 28803996
[TBL] [Abstract][Full Text] [Related]
7. Preoperative Metyrosine Improves Cardiovascular Outcomes for Patients Undergoing Surgery for Pheochromocytoma and Paraganglioma.
Wachtel H; Kennedy EH; Zaheer S; Bartlett EK; Fishbein L; Roses RE; Fraker DL; Cohen DL
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S646-54. PubMed ID: 26374407
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic agents in the management of pheochromocytoma.
Juan D
South Med J; 1982 Feb; 75(2):211-6. PubMed ID: 6120573
[TBL] [Abstract][Full Text] [Related]
9. The Role for Metyrosine in the Treatment of Patients With Pheochromocytoma and Paraganglioma.
Gruber LM; Jasim S; Ducharme-Smith A; Weingarten T; Young WF; Bancos I
J Clin Endocrinol Metab; 2021 May; 106(6):e2393-e2401. PubMed ID: 33693908
[TBL] [Abstract][Full Text] [Related]
10. Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma.
Kuchel O; Buu NT; Edwards DJ
J Lab Clin Med; 1990 Apr; 115(4):449-53. PubMed ID: 1969915
[TBL] [Abstract][Full Text] [Related]
11. Childhood pheochromocytoma: treatment with alpha methyl tyrosine for resistant hypertension.
Robinson RG; DeQuattro V; Grushkin CM; Lieberman E
J Pediatr; 1977 Jul; 91(1):143-7. PubMed ID: 17659
[TBL] [Abstract][Full Text] [Related]
12. Alpha blockade in preoperative preparation of patients with pheochromocytomas.
Kocak S; Aydintug S; Canakci N
Int Surg; 2002; 87(3):191-4. PubMed ID: 12403097
[TBL] [Abstract][Full Text] [Related]
13. The Duration of Preoperative Administration of Single
Tian J; Bao Z; Yuan Y; Fang D; Zhan Y; Wang T; Zhang Z; Liqun Z
Biomed Res Int; 2019; 2019():2613137. PubMed ID: 31828097
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Preoperative Alpha-blockade for Resection of Paraganglioma and Pheochromocytoma.
Zhu CY; Hong JC; Kamdar NV; Hu MY; Tseng CH; Lee JS; Kuo EJ; Yu R; Isorena J; Yeh MW; Livhits MJ
Endocr Pract; 2022 Sep; 28(9):889-896. PubMed ID: 35809774
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial.
Buitenwerf E; Osinga TE; Timmers HJLM; Lenders JWM; Feelders RA; Eekhoff EMW; Haak HR; Corssmit EPM; Bisschop PHLT; Valk GD; Veldman RG; Dullaart RPF; Links TP; Voogd MF; Wietasch GJKG; Kerstens MN
J Clin Endocrinol Metab; 2020 Jul; 105(7):2381-91. PubMed ID: 31714582
[TBL] [Abstract][Full Text] [Related]
16. Preoperative treatment and survival of patients with pheochromocytomas.
Sand J; Salmi J; Saaristo J; Auvinen O
Ann Chir Gynaecol; 1997; 86(3):230-2. PubMed ID: 9435934
[TBL] [Abstract][Full Text] [Related]
17. Influence of duration of preoperative treatment with phenoxybenzamine and secretory phenotypes on perioperative hemodynamics and postoperative outcomes in pheochromocytoma and paraganglioma.
Yao Y; Guo Y; Fan J; Lin T; Wang L; Zhang S
Front Endocrinol (Lausanne); 2023; 14():1139015. PubMed ID: 37152936
[TBL] [Abstract][Full Text] [Related]
18. Advances in the diagnosis and treatment of pheochromocytoma.
Havlik RJ; Cahow CE; Kinder BK
Arch Surg; 1988 May; 123(5):626-30. PubMed ID: 3282495
[TBL] [Abstract][Full Text] [Related]
19. Adrenergic blockade in pheochromocytoma.
Modlinger RS; Ertel NH; Hauptman JB
Arch Intern Med; 1983 Dec; 143(12):2245-6. PubMed ID: 6139986
[No Abstract] [Full Text] [Related]
20. Pheochromocytoma: a review on preoperative treatment with phenoxybenzamine or doxazosin.
van der Zee PA; de Boer A
Neth J Med; 2014 May; 72(4):190-201. PubMed ID: 24829175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
